Cresce l’armadietto dei medicinali europeo, umano e veterinario: a essere raccomandati per l’approvazione anche 11 medicinali ad uso animale, di cui sei nuove sostanze attive
Of Aboutpharma Online editorial staff – 11 maggio 2017 – Aboutpharma
There are 81 new medicines that the European Medicines Agency (EMA) has recommended for placing on the market in 2016, 27 of which are new active ingredients: "Many of these innovative substances are based on the progress made in biomedical science and have the potential to make a difference for patients" specifies the Agency in its annual report for 2016.
There EMA annual report it also highlights some of the main projects, initiatives and achievements of the Agency in 2016. Among these, the launch of Prime (PRIority MEdicines), an initiative to support the development of medicines that address unmet medical needs and for the clinical publication of experimental data for new medicines, which has transformed the EMA into one of the most transparent medicines regulators in the world. The report also includes new ways to collect drug data such as big data, patient registries and real-world data, and EMA's contribution to addressing public health challenges such as antimicrobial resistance and the Zika epidemic.